Once-Daily Eprosartan Mesylate in the Treatment of Elderly Patients With Isolated Systolic Hypertension: Data From a 13-Week Double-Blind, Placebo-Controlled, Parallel, Multicenter Study

Journal of Human Hypertension - United Kingdom
doi 10.1038/sj.jhh.1001704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Corrections To: Once-Daily Controlled-Release Pregabalin in the Treatment of Patients With Fibromyalgia: A Phase III, Double-Blind, Randomized Withdrawal, Placebo-Controlled Study

Current Medical Research and Opinion
Medicine
2017English

Ketanserin in Essential Hypertension: A Double-Blind, Placebo-Controlled Study.

Postgraduate Medical Journal
Medicine
1985English

Lithium as Add-On to Quetiapine XR in Adult Patients With Acute Mania: A 6-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study

International Journal of Bipolar Disorders
PsychiatryMental HealthBiological Psychiatry
2014English

Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-Week Multicenter Placebo-Controlled Double-Blind Parallel Group Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

BP-C1 in Treatment of Patients With Stage IV Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study and Additional Open-Label Treatment Phase.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine With Placebo, Along With Oral Naltrexone, in the Treatment of Opioid Dependent Patients

Journal of Evolution of Medical and Dental Sciences
2015English

N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2015English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy